US 8518390
Treatment of stroke and other acute neural degenerative disorders via intranasal administration of umbilical cord-derived cells
granted A61KA61K35/30A61K35/48
Quick answer
US patent 8518390 (Treatment of stroke and other acute neural degenerative disorders via intranasal administration of umbilical cord-derived cells) held by Advanced Technologies and Regenerative Medicine, LLC expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Advanced Technologies and Regenerative Medicine, LLC
- Grant date
- Tue Aug 27 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 31
- CPC classes
- A61K, A61K35/30, A61K35/48, A61K35/51, A61K38/13